VeriMom2-bromo-2-nitropropane-1,3-diol (formaldehyde releaser) est-il sûr pendant la grossesse ?
CIR amended safety assessment concluded bronopol (2‑bromo‑2‑nitropropane‑1,3‑diol) is safe in cosmetics at reported use concentrations (≤0.1%) and reported animal reproductive studies showed no consistent teratogenicity or impaired fertility at relevant doses; no harmonised reproductive classification (H360/H361 harmonised) was identified in Annex VI for reproductive effects. Dermal exposure from cosmetic use is low but measurable, so exposure score=1. (CIR; ECHA; animal studies summarized in CIR).
Related ingredients
Frequently asked questions
- 2-bromo-2-nitropropane-1,3-diol (formaldehyde releaser) est-il sûr pendant la grossesse ?
- CIR amended safety assessment concluded bronopol (2‑bromo‑2‑nitropropane‑1,3‑diol) is safe in cosmetics at reported use concentrations (≤0.1%) and reported animal reproductive studies showed no consistent teratogenicity or impaired fertility at relevant doses; no harmonised reproductive classification (H360/H361 harmonised) was identified in Annex VI for reproductive effects. Dermal exposure from cosmetic use is low but measurable, so exposure score=1. (CIR; ECHA; animal studies summarized in CIR).
- 2-bromo-2-nitropropane-1,3-diol (formaldehyde releaser) est-il sûr pendant l'allaitement ?
- No clinical or animal evidence indicating specific lactation/transfer risks or human developmental toxicity at cosmetic use levels in the cited assessments; CIR found no reproductive/teratogenic concern at normal cosmetic concentrations. Dermal absorption from cosmetics is low but measurable, so exposure score=1. (CIR; animal studies summarized in CIR).
- 2-bromo-2-nitropropane-1,3-diol (formaldehyde releaser) est-il sûr pour la peau de bébé ?
- No infant‑specific reproductive or developmental hazard data were found; CIR safety assessment and animal studies do not indicate developmental/teratogenic hazard at cosmetic use levels. Because infant skin has higher surface‑area‑to‑weight and an immature barrier and bronopol has measurable dermal activity in irritation/sensitization tests, exposure score is increased by +1 for ages 0–3 (adult e=1 → baby e=2). Note also documented risks for contact allergy and potential formation of small amounts of formaldehyde/nitrite under certain conditions (relevant for skin sensitivity). (CIR; PubMed patch‑test studies; EWG).
- Comment VeriMom évalue-t-il 2-bromo-2-nitropropane-1,3-diol (formaldehyde releaser) ?
- VeriMom évalue 2-bromo-2-nitropropane-1,3-diol (formaldehyde releaser) à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à 2-bromo-2-nitropropane-1,3-diol (formaldehyde releaser) pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à 2-bromo-2-nitropropane-1,3-diol (formaldehyde releaser) basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.